|
Management of menopausal symptoms in women with a history of breast cancer |
Early breast cancer |
2016 |
|
Clinical guidance for the management of lobular carcinoma in situ |
Early breast cancer |
2016 |
|
Hypofractionated radiotherapy for early (operable) breast cancer |
Early breast cancer |
2015 |
|
Clinical guidance for responding to suffering in adults with cancer |
Psychosocial care |
2014 |
|
First-line chemotherapy for the treatment of women with epithelial ovarian cancer |
Ovarian cancer |
2014 |
|
CNS metastases in women with secondary breast cancer |
Advanced Breast Cancer |
2014 |
|
Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation |
Early breast cancer |
2014 |
|
Follow up of women with epithelial ovarian cancer |
Ovarian cancer |
2012 |
|
Recommendations for the identification and management of fear of cancer recurrence in adult cancer survivors |
Psychosocial care |
2012 |
|
Recommendations for use of bisphosphonates in early breast cancer |
Early breast cancer |
2011 |
|
Recommendations for use of hypofractionated radiotherapy in early (operable) breast cancer |
Early breast cancer |
2011 |
|
Recommendations for staging and managing the axilla in early (operable) breast cancer |
Early breast cancer |
2011 |
|
Recommendations for the management of women at high risk of ovarian cancer |
Ovarian cancer |
2011 |
|
Recommendations for use of bisphosphonates for advanced breast cancer |
Advanced Breast Cancer |
2011 |
|
Recommendations for use of chemotherapy for the treatment of advanced breast cancer |
Advanced Breast Cancer |
2010 |
|
Recommendations for follow-up of women with early breast cancer |
Early breast cancer |
2010 |
|
Recommendations for use of Sentinel node biopsy in early (operable) breast cancer |
Early breast cancer |
2008 |
|
Recommendations for use of endocrine therapy for the treatment of hormone receptor-positive advanced breast cancer |
Advanced Breast Cancer |
2008 |
|
Recommendations for use of Taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer |
Early breast cancer |
2008 |
|
Recommendations for use of Trastuzumab (Herceptin®) for the treatment of HER2-positive breast cancer |
Advanced Breast Cancer |
2007 |
